---
title: "ZHEJIANG ZHENYUAN: Expected net profit in 2024 to decline by 55.2%-68% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225354880.md"
description: "ZHEJIANG ZHENYUAN expects its net profit in 2024 to decline by 55.2%-68% year-on-year, with the net profit attributable to shareholders of the listed company expected to be between 26.1256 million yuan and 36.5759 million yuan. The net profit after deducting non-recurring gains and losses is expected to be between 20.3352 million yuan and 28.4693 million yuan, with basic earnings per share expected to be between 0.08 yuan/share and 0.11 yuan/share. The performance change is mainly affected by factors such as the contraction of the pharmaceutical wholesale business scale, an increase in accounts receivable, and an increase in financial expenses"
datetime: "2025-01-17T12:55:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225354880.md)
  - [en](https://longbridge.com/en/news/225354880.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225354880.md)
---

# ZHEJIANG ZHENYUAN: Expected net profit in 2024 to decline by 55.2%-68% year-on-year

ZHEJIANG ZHENYUAN announced that from January 1, 2024, to December 31, 2024, the net profit attributable to shareholders of the listed company is expected to be between 26.1256 million yuan and 36.5759 million yuan, a decrease of 55.2% to 68% compared to the same period last year. The net profit after deducting non-recurring gains and losses is expected to be between 20.3352 million yuan and 28.4693 million yuan, a decrease of 63.6% to 74% compared to the same period last year. The basic earnings per share are expected to be between 0.08 yuan/share and 0.11 yuan/share. The company's performance changes are mainly due to factors such as the contraction of the pharmaceutical wholesale business scale, an increase in accounts receivable, and an increase in financial expenses

### Related Stocks

- [000705.CN](https://longbridge.com/en/quote/000705.CN.md)
- [600721.CN](https://longbridge.com/en/quote/600721.CN.md)
- [002727.CN](https://longbridge.com/en/quote/002727.CN.md)
- [301096.CN](https://longbridge.com/en/quote/301096.CN.md)
- [600998.CN](https://longbridge.com/en/quote/600998.CN.md)

## Related News & Research

- [Patrizia executive director James Muir sells shares worth EUR 60,778](https://longbridge.com/en/news/296066905.md)
- [14:56 ETBernhard Capital-Backed Aventia Broadens Infrastructure Capabilities Through Bryant Hammett & Associates Acquisition](https://longbridge.com/en/news/296260824.md)
- [Insider Selling: Alvopetro Energy (CVE:ALV) Director Sells 10,200 Shares](https://longbridge.com/en/news/296081468.md)
- [Arizona Eagle Mining completes acquisition of three past-producing high-grade silver mines in Arizona](https://longbridge.com/en/news/296081842.md)
- [ÖSSUR RENEWS PARTNERSHIP WITH HUNTER WOODHALL THROUGH 2028 | EMBLA Stock News](https://longbridge.com/en/news/296243594.md)